MRK vs PANW: Which Is the Better Buy?

Side-by-side comparison of Merck & Co., Inc. and Palo Alto Networks, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Merck & Co., Inc. Β· Healthcare
$147.17
-4.1% upside to fair value
Med Conviction Grade C
VS
Palo Alto Networks, Inc. Β· Technology
$374.74
-5.2% upside to fair value
Med Conviction Grade C High Quality
QuantHub Verdict
MRK has more upside to fair value (-4.1%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric MRK PANW
Current Price $147.17 $374.74
Fair Value Estimate $141.07 $355.11
Upside to Fair Value -4.1% -5.2%
Market Cap $363.5B $305.4B
Forward P/E β€” β€”
EV / EBITDA 29.6x 569.8x
Price / Sales 5.5x 26.6x
Price / FCF 22.6x 64.0x
Revenue Growth YoY +5.1% +34.4%
Gross Margin 75.4% 70.4%
Operating Margin 16.7% 6.1%
Return on Equity 6.6% 1.7%
Dividend Yield 2.31% 0%
FCF Yield 4.42% 1.56%
Analyst Consensus Buy Strong Buy
Investment Thesis
MRK β€” Merck & Co., Inc.
Merck & Co., Inc. is a global healthcare leader with two core divisions, Pharmaceuticals and Animal Health, spanning oncology, vaccines, acute hospital care, immunology, neuroscience, virology, cardiovascular and diabetes, and it employs roughly 74,000 people under CEO Robert Davis. The business quality is medium: TTM gross margin of 75.4% and TTM operating margin of 16.7% reflect a genuinely hig…
PANW β€” Palo Alto Networks, Inc.
Palo Alto Networks is a global cybersecurity leader built around next-generation firewalls, the Panorama management platform, and a broad subscription portfolio spanning threat prevention, cloud security, secure access, and security analytics, sold to medium and large enterprises, service providers, and governments through direct and channel distribution. The business quality is genuinely high on…
Accumulation Zones
Metric MRK PANW
Zone Low $105.80 $266.33
Zone High $119.91 $301.84
In Buy Zone? No No
← MRK Research    PANW Research β†’    All Research